231 related articles for article (PubMed ID: 15500550)
1. High levels of p53 protein expression do not correlate with p53 mutations in hepatocellular carcinoma.
Anzola M; Saiz A; Cuevas N; Lopez-Martinez M; Martinez de Pancorbo MA; Burgos JJ
J Viral Hepat; 2004 Nov; 11(6):502-10. PubMed ID: 15500550
[TBL] [Abstract][Full Text] [Related]
2. Correlation of immunohistochemical staining and mutations of p53 in human hepatocellular carcinoma.
Hsia CC; Nakashima Y; Thorgeirsson SS; Harris CC; Minemura M; Momosaki S; Wang NJ; Tabor E
Oncol Rep; 2000; 7(2):353-6. PubMed ID: 10671685
[TBL] [Abstract][Full Text] [Related]
3. p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status.
Tolbert DM; Noffsinger AE; Miller MA; DeVoe GW; Stemmermann GN; Macdonald JS; Fenoglio-Preiser CM
Mod Pathol; 1999 Jan; 12(1):54-60. PubMed ID: 9950163
[TBL] [Abstract][Full Text] [Related]
4. The clinical significance of p53 gene mutation in hepatocellular carcinomas from Japan.
Hayashi H; Sugio K; Matsumata T; Adachi E; Takenaka K; Sugimachi K
Hepatology; 1995 Dec; 22(6):1702-7. PubMed ID: 7489977
[TBL] [Abstract][Full Text] [Related]
5. Prognosis in patients with hepatocellular carcinoma correlates to mutations of p53 and/or hMSH2 genes.
Yano M; Hamatani K; Eguchi H; Hirai Y; MacPhee DG; Sugino K; Dohi K; Itamoto T; Asahara T
Eur J Cancer; 2007 Apr; 43(6):1092-100. PubMed ID: 17350822
[TBL] [Abstract][Full Text] [Related]
6. p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation.
Volkmann M; Hofmann WJ; Müller M; Räth U; Otto G; Zentgraf H; Galle PR
Oncogene; 1994 Jan; 9(1):195-204. PubMed ID: 8302580
[TBL] [Abstract][Full Text] [Related]
7. Target gene modulation in hepatocellular carcinomas by decreased DNA-binding of p53 mutations.
Kubicka S; Trautwein C; Niehof M; Manns M
Hepatology; 1997 Apr; 25(4):867-73. PubMed ID: 9096590
[TBL] [Abstract][Full Text] [Related]
8. Expression of p53 gene in 184 unifocal hepatocellular carcinomas: association with tumor growth and invasiveness.
Hsu HC; Tseng HJ; Lai PL; Lee PH; Peng SY
Cancer Res; 1993 Oct; 53(19):4691-4. PubMed ID: 8402647
[TBL] [Abstract][Full Text] [Related]
9. p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein.
Griewe GL; Dean RC; Zhang W; Young D; Sesterhenn IA; Shanmugam N; McLeod DG; Moul JW; Srivastava S
Prostate Cancer Prostatic Dis; 2003; 6(4):281-5. PubMed ID: 14663467
[TBL] [Abstract][Full Text] [Related]
10. p53 gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese.
Ng IO; Chung LP; Tsang SW; Lam CL; Lai EC; Fan ST; Ng M
Oncogene; 1994 Mar; 9(3):985-90. PubMed ID: 8108145
[TBL] [Abstract][Full Text] [Related]
11. GEP associates with wild-type p53 in hepatocellular carcinoma.
Cheung ST; Wong SY; Lee YT; Fan ST
Oncol Rep; 2006 Jun; 15(6):1507-11. PubMed ID: 16685387
[TBL] [Abstract][Full Text] [Related]
12. Loss of CD95 expression is linked to most but not all p53 mutants in European hepatocellular carcinoma.
Volkmann M; Schiff JH; Hajjar Y; Otto G; Stilgenbauer F; Fiehn W; Galle PR; Hofmann WJ
J Mol Med (Berl); 2001 Oct; 79(10):594-600. PubMed ID: 11692157
[TBL] [Abstract][Full Text] [Related]
13. [p53 gene mutation in hepatocellular carcinoma].
Jiang W; Lu Q; Pan G
Zhonghua Wai Ke Za Zhi; 1998 Sep; 36(9):531-2. PubMed ID: 11825456
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of p53 in a large series of patients with hepatocellular carcinoma: a clinicopathological correlation.
Caruso ML; Valentini AM
Anticancer Res; 1999; 19(5B):3853-6. PubMed ID: 10628323
[TBL] [Abstract][Full Text] [Related]
15. Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma.
Moriyama Y; Nishiguchi S; Tamori A; Koh N; Yano Y; Kubo S; Hirohashi K; Otani S
Clin Cancer Res; 2001 May; 7(5):1293-8. PubMed ID: 11350897
[TBL] [Abstract][Full Text] [Related]
16. Alteration of the p14(ARF) gene and p53 status in human hepatocellular carcinomas.
Ito T; Nishida N; Fukuda Y; Nishimura T; Komeda T; Nakao K
J Gastroenterol; 2004; 39(4):355-61. PubMed ID: 15168247
[TBL] [Abstract][Full Text] [Related]
17. [Mutation of p53 gene and expression of alphafetoprotein during hepatocarcinogenesis].
Zou HQ; Tang ZY; Ye SL
Zhonghua Yi Xue Za Zhi; 1994 Aug; 74(8):474-5, 517-8. PubMed ID: 7527728
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between p53 gene mutation and protein expression in 30 cases of human lung cancer].
Zhang J; Zheng J; Fang W
Zhonghua Yi Xue Za Zhi; 1998 Nov; 78(11):846-9. PubMed ID: 11038779
[TBL] [Abstract][Full Text] [Related]
19. p53 mutation and detection of p53 protein expression in oral leukoplakia and oral squamous cell carcinoma.
Ries JC; Schreiner D; Steininger H; Girod SC
Anticancer Res; 1998; 18(3B):2031-6. PubMed ID: 9677462
[TBL] [Abstract][Full Text] [Related]
20. p53 gene mutation in relation to p53 protein accumulation in male and female breast cancer.
Nayak BK; Baral RN; Das BR
Neoplasma; 1996; 43(5):305-10. PubMed ID: 8996549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
